Intervention Review

Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome

  1. Edward Hughes1,*,
  2. John Collins2,
  3. Patrick Vandekerckhove3

Editorial Group: Cochrane Menstrual Disorders and Subfertility Group

Published Online: 22 APR 1996

Assessed as up-to-date: 12 FEB 1996

DOI: 10.1002/14651858.CD000087


How to Cite

Hughes E, Collins J, Vandekerckhove P. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. Cochrane Database of Systematic Reviews 1996, Issue 1. Art. No.: CD000087. DOI: 10.1002/14651858.CD000087.

Author Information

  1. 1

    McMaster University, Department of Obstetrics and Gynaecology, Hamilton, Ontario, Canada

  2. 2

    McMaster University, Obstetrics and Gynaecology, Mahone Bay, Nova Scotia, Canada

  3. 3

    St Mary's Hospital, IOW Healthcare NHS Trust, Isle of Wight, UK

*Edward Hughes, Department of Obstetrics and Gynaecology, McMaster University, 1200 Main St West, Room 4D14, Hamilton, Ontario, L8N 3Z5, Canada. hughese@mcmaster.ca.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 22 APR 1996

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Neriman Bayram, Madelon van Wely, Fulco Van der Veen, Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome, The Cochrane Library,